|
RAB21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.323210E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.975800E-03 |
| Normal-vs-Stage2 |
6.523600E-02 |
| Normal-vs-Stage3 |
5.017600E-04 |
| Normal-vs-Stage4 |
3.080600E-03 |
| Stage1-vs-Stage2 |
7.600600E-01 |
| Stage1-vs-Stage3 |
2.354200E-01 |
| Stage1-vs-Stage4 |
3.572000E-01 |
| Stage2-vs-Stage3 |
2.570400E-01 |
| Stage2-vs-Stage4 |
3.147200E-01 |
| Stage3-vs-Stage4 |
9.754600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.739360E-03 |
| Normal-vs-AfricanAmerican |
4.654400E-01 |
| Normal-vs-Asian |
1.922190E-02 |
| Caucasian-vs-AfricanAmerican |
1.911020E-01 |
| Caucasian-vs-Asian |
9.571400E-01 |
| AfricanAmerican-vs-Asian |
2.682200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.414900E-04 |
| Normal-vs-Female |
5.495100E-03 |
| Male-vs-Female |
1.155450E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.193800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.558560E-03 |
| Normal-vs-Age(61-80Yrs) |
8.595200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.055240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.644000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.323560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.662600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.520600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.888800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.510800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.178800E-01 |
| Classical-VS-Follicular |
1.118280E-02 |
| Classical-VS-Other |
2.013200E-01 |
| Classical-VS-Normal |
1.729730E-02 |
| Tall-VS-Follicular |
3.743200E-01 |
| Tall-VS-Other |
3.392000E-01 |
| Tall-VS-Normal |
1.777670E-02 |
| Follicular-VS-Other |
7.299200E-01 |
| Follicular-VS-Normal |
8.200900E-04 |
| Other-VS-Normal |
5.675700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.792890E-04 |
| Normal-vs-N1 |
3.137700E-03 |
| N0-vs-N1 |
7.920800E-01 |
|
|
